Clinical Trial Update: LTFU Study of Subjects With Cervical SCI Who Received AST-OPC1

View source ↗

Summary

This clinical trial update describes a follow-up study of subjects with cervical spinal cord injury who previously received AST-OPC1. The study is currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• AST-OPC1

Snippet

Sponsor: Lineage Cell Therapeutics, Inc. | Conditions: Spinal Cord Injuries | Status: ACTIVE_NOT_RECRUITING